Device-based Therapy for Hypertension
暂无分享,去创建一个
Manish Saxena | Felix Mahfoud | A. Pathak | F. Mahfoud | Melvin D. Lobo | Atul Pathak | M. Lobo | Fu L. Ng | F. Ng | M. Saxena
[1] R. Bandler,et al. Viscerotopic organization of neurons subserving hypotensive reactions within the midbrain periaqueductal grey: a correlative functional and anatomical study , 1991, Brain Research.
[2] G. Chatellier,et al. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. , 2015, European heart journal.
[3] A. Stanton,et al. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial , 2015, The Lancet.
[4] I. Dasgupta,et al. Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic , 2016, Journal of Human Hypertension.
[5] W. Elliott. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research , 2009 .
[6] P. Gosse,et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial , 2015, The Lancet.
[7] Jens Jordan,et al. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. , 2010, Journal of the American College of Cardiology.
[8] D. Paterson,et al. Differentiated Baroreflex Modulation of Sympathetic Nerve Activity During Deep Brain Stimulation in Humans , 2014, Hypertension.
[9] R. Victor. Carotid baroreflex activation therapy for resistant hypertension , 2015, Nature Reviews Cardiology.
[10] J. Nährig,et al. Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model , 2012, Journal of hypertension.
[11] T. Lovick. Ventrolateral medullary lesions block the antinociceptive and cardiovascular responses elicited by stimulating the dorsal periaqueductal grey matter in rats , 1985, Pain.
[12] A. Fletcher,et al. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population , 1995, BMJ.
[13] G. Bakris,et al. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. , 2012, Journal of the American Society of Hypertension : JASH.
[14] B. Whipp,et al. Immediate effects of bilateral carotid body resection on total respiratory resistance and compliance in humans. , 2004, Advances in experimental medicine and biology.
[15] J. Staessen,et al. Blood pressure changes after renal denervation at 10 European expert centers , 2013, Journal of Human Hypertension.
[16] Mortimer Gierthmuehlen,et al. Effect of selective vagal nerve stimulation on blood pressure, heart rate and respiratory rate in rats under metoprolol medication , 2016, Hypertension Research.
[17] Daniel W. Jones,et al. A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research , 2008 .
[18] H. Krum,et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.
[19] M. Böhm,et al. Reduced Effect of Percutaneous Renal Denervation on Blood Pressure in Patients With Isolated Systolic Hypertension , 2015, Hypertension.
[20] R. Wachter,et al. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. , 2012, Journal of the American Society of Hypertension : JASH.
[21] H. Krum,et al. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. , 2014, European heart journal.
[22] M. Andrassy,et al. Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry , 2014, Clinical Research in Cardiology.
[23] J. Paton,et al. Arteriovenous Anastomosis: Is This the Way to Control Hypertension? , 2014, Hypertension.
[24] Brad S. Hubbard,et al. A novel non-vascular system to treat resistant hypertension. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[25] Deepak L. Bhatt,et al. Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety , 2014, The New England journal of medicine.
[26] J F R Paton,et al. Deep brain stimulation relieves refractory hypertension , 2011, Neurology.
[27] E. Regar,et al. Multimodality Intra-Arterial Imaging Assessment of the Vascular Trauma Induced by Balloon-Based and Nonballoon-Based Renal Denervation Systems , 2015, Circulation. Cardiovascular interventions.
[28] Thomas Stieglitz,et al. Blood pressure control with selective vagal nerve stimulation and minimal side effects , 2014, Journal of neural engineering.
[29] F. Ikeno,et al. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience. , 2016, JACC. Cardiovascular interventions.
[30] Ajay K. Jain,et al. The ROX coupler: Creation of a fixed iliac arteriovenous anastomosis for the treatment of uncontrolled systemic arterial hypertension, exploiting the physical properties of the arterial vasculature , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[31] Elena G Tolkacheva,et al. Intermittent electrical stimulation of the right cervical vagus nerve in salt-sensitive hypertensive rats: effects on blood pressure, arrhythmias, and ventricular electrophysiology , 2015, Physiological reports.
[32] C. Cooper,et al. An arteriovenous fistula increases exercise capacity in patients with COPD. , 2010, Chest.
[33] D. Paterson,et al. Deep brain stimulation of the periaqueductal grey induces vasodilation in humans. , 2011, Hypertension.
[34] A. Zanchetti,et al. Functional role of renal afferents. , 1991, Physiological reviews.
[35] M. Caulfield,et al. Joint UK societies’ 2014 consensus statement on renal denervation for resistant hypertension , 2014, Heart.
[36] J. Staessen,et al. Renal denervation in treatment-resistant hypertension: a reappraisal. , 2015, Current opinion in pharmacology.
[37] W. Anderson,et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. , 1988, Hypertension.
[38] J. Paton,et al. The Carotid Body as a Therapeutic Target for the Treatment of Sympathetically Mediated Diseases , 2013, Hypertension.
[39] Giuseppe Mancia,et al. The Autonomic Nervous System and Hypertension , 2014, Circulation research.
[40] R. Wachter,et al. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction. , 2015, JACC. Heart failure.
[41] R. Virmani,et al. Renal denervation therapy for hypertension: pathways for moving development forward. , 2015, Journal of the American Society of Hypertension : JASH.
[42] K. Kuck,et al. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[43] A. Kroon,et al. Bilateral or Unilateral Stimulation for Baroreflex Activation Therapy , 2015, Hypertension.
[44] J P Gassler,et al. Baroreflex activation therapy in hypertension , 2014, Journal of Human Hypertension.
[45] A. Kroon,et al. Effects of Chronic Baroreceptor Stimulation on the Autonomic Cardiovascular Regulation in Patients With Drug-Resistant Arterial Hypertension , 2009, Hypertension.
[46] J. Longhurst,et al. Long-Lasting Reduction of Blood Pressure by Electroacupuncture in Patients with Hypertension: Randomized Controlled Trial , 2015, Medical acupuncture.
[47] T. Stieglitz,et al. Haemodynamic Responses to Selective Vagal Nerve Stimulation under Enalapril Medication in Rats , 2016, PloS one.
[48] Ajay K. Jain,et al. Central arteriovenous anastomosis for hypertension: it is not all about sympathomodulation. , 2015, Future cardiology.
[49] G. Bakris,et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. , 2011, Journal of the American College of Cardiology.
[50] M. Esler,et al. The sympathetic system and hypertension. , 2000, American journal of hypertension.
[51] R. Wachter,et al. Impact of Baroreflex Activation Therapy on Renal Function - A Pilot Study , 2014, American Journal of Nephrology.
[52] T. Zelinka,et al. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis , 2013, Journal of hypertension.
[53] R. Whitbourn,et al. First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension , 2015, Hypertension.
[54] K. Shipman. A controlled trial of renal denervation for resistant hypertension , 2014 .
[55] Deepak L. Bhatt,et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. , 2015, European heart journal.
[56] M. Caulfield,et al. Renal artery sympathetic denervation: observations from the UK experience , 2016, Clinical Research in Cardiology.
[57] B. Geršak,et al. Frequency dependent effect of selective biphasic left vagus nerve stimulation on heart rate and arterial pressure , 2012 .
[58] J. Longhurst,et al. Electroacupuncture modulation of reflex hypertension in rats: role of cholecystokinin octapeptide. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.
[59] C. Di Mario,et al. Renal denervation for the management of resistant hypertension , 2015, Integrated blood pressure control.
[60] Ajay K. Jain,et al. Renal Sympathetic Denervation - A Review of Applications in Current Practice. , 2013, Interventional cardiology.
[61] T. Lüscher,et al. Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity® catheter system and the EnligHTN™ multi-electrode renal denervation catheter , 2013, European heart journal.
[62] Krzysztof Bartus,et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2009, The Lancet.
[63] E. Dolan,et al. Creation of an iliac arteriovenous shunt lowers blood pressure in chronic obstructive pulmonary disease patients with hypertension. , 2014, Journal of vascular surgery.
[64] A. Stanton,et al. Central Iliac Arteriovenous Anastomosis for Hypertension: Targeting Mechanical Aspects of the Circulation , 2015, Current Hypertension Reports.
[65] J. Bisognano,et al. The prevalence, incidence, prognosis, and associated conditions of resistant hypertension. , 2014, Seminars in nephrology.